Owens & Minor (NYSE:OMI) Releases Q4 2024 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share guidance of 0.520-0.550 for the period, compared to the consensus earnings per share estimate of 0.530. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. Owens & Minor also updated its FY 2024 guidance to 1.500-1.530 EPS.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on OMI. Barclays cut their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. UBS Group cut their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Citigroup reduced their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. Finally, Robert W. Baird dropped their price target on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $18.50.

Owens & Minor Stock Performance

Owens & Minor stock traded down $4.01 during midday trading on Monday, hitting $10.23. 1,504,415 shares of the company’s stock were exchanged, compared to its average volume of 546,443. The firm’s 50 day simple moving average is $13.86 and its 200 day simple moving average is $14.32. Owens & Minor has a 12-month low of $10.54 and a 12-month high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The stock has a market cap of $788.53 million, a price-to-earnings ratio of -15.73, a price-to-earnings-growth ratio of 0.40 and a beta of 0.48.

Owens & Minor (NYSE:OMI) last announced its earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same period last year, the business posted $0.44 EPS. The company’s revenue was up 5.0% on a year-over-year basis. Equities research analysts predict that Owens & Minor will post 1.49 EPS for the current year.

Insider Buying and Selling at Owens & Minor

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the transaction, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 2.62% of the stock is owned by corporate insiders.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.